[1] |
Mlynarsky L, Menachem Y, Shibolet O.
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go[J]. World J HepatolWorld J Hepatol, 2015, 7(3): 566-574.
doi: 10.4254/wjh.v7.i3.566 |
[2] |
Cassinotto C, Aubé C, Dohan A.
Diagnosis of hepatocellular carcinoma: An update on international guidelines[J]. Diagn Interv ImagingDiagn Interv Imaging, 2017, 98(5): 379-391.
doi: 10.1016/j.diii.2017.01.014 |
[3] |
赵年, 李春华, 李德秀, 等.
MRI与CT多期动态增强扫描诊断肝硬化伴肝癌的效果比较[J]. 中国CT和MRI杂志中国CT和MRI杂志, 2017, 15(5): 85-87, 99.
doi: 10.3969/j.issn.1672-5131.2017.05.026 Zhao N, Li CH, Li DX, et al. Comparison of the Effects of MRI and CT Multi-phase Dynamic Contrast-enhanced Scan in the Diagnosis of Liver Cirrhosis with Liver Cancer[J]. Chin J CT and MRIChin J CT and MRI, 2017, 15(5): 85-87, 99. doi: 10.3969/j.issn.1672-5131.2017.05.026 |
[4] |
Choi SH, Byun JH, Lim YS, et al.
Diagnostic criteria for hepatocellular carcinoma ≤3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging[J]. J HepatolJ Hepatol, 2016, 64(5): 1099-1107.
doi: 10.1016/j.jhep.2016.01.018 |
[5] |
Yu MH, Kim JH, Yoon JH, et al.
Small (≤1cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging[J]. RadiologyRadiology, 2014, 271(3): 748-760.
doi: 10.1148/radiol.14131996 |
[6] |
Kierans AS, Kang SK, Rosenkrantz AB.
The Diagnostic Performance of Dynamic Contrast-enhanced MR Imaging for Detection of Small Hepatocellular Carcinoma Measuring Up to 2 cm: A Meta-Analysis[J]. RadiologyRadiology, 2016, 278(1): 82-94.
doi: 10.1148/radiol.2015150177 |
[7] |
Hanna RF, Miloushev VZ, Tang A, et al.
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma[J]. Abdom Radiol (NY)Abdom Radiol (NY), 2016, 41(1): 71-90.
doi: 10.1007/s00261-015-0592-8 |
[8] |
Li X, Li C, Wang R, et al. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis[J/OL]. PLoS One, 2015, 10(12): e0144247 [2018-07-05]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668097/pdf/pone.0144247.pdf. DOI: 10.1371/journal.pone.0144247. |
[9] |
徐安波, 丁朝鹏, 孟凡杰, 等.
磁共振动态增强和DWI在肝结节性病变与小肝癌诊断中的应用分析[J]. 医学影像学杂志医学影像学杂志, 2017, 27(5): 954-957.
Xu AB, Ding CP, Meng FJ, et al. Application of dynamic contrast-enhanced MRI and DWI in the diagnosis of hepatic nodular lesions and small hepatocellular carcinoma[J]. J Med ImagingJ Med Imaging, 2017, 27(5): 954-957. |
[10] |
Park SH, Chung YE, Hong HS, et al.
Detection of Hepatocellular Carcinoma: Comparison of Gadoxetic Acid-Enhanced MRI, Diffusion-Weighted Imaging, and Combined Interpretation at 3T MRI[J]. Korean Soc RadiolKorean Soc Radiol, 2013, 69(3): 213-222.
doi: 10.3348/jksr.2013.69.3.213 |
[11] |
Le MF, Durieux M, Bancel B, et al.
Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver[J]. Magn Reson ImagingMagn Reson Imaging, 2012, 30(5): 656-665.
doi: 10.1016/j.mri.2012.01.002 |
[12] |
Park MJ, Kim YK, Lee MW, et al.
Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns[J]. RadiologyRadiology, 2012, 264(3): 761-770.
doi: 10.1148/radiol.12112517 |
[13] |
Di MM, Di MR, De Filippis G, et al.
Detection of small (≤2 cm) HCC in cirrhotic patients: added value of diffusion MR-imaging[J]. Abdom ImagingAbdom Imaging, 2013, 38(6): 1254-1262.
doi: 10.1007/s00261-013-0009-5 |
[14] |
Park MJ, Kim YK, Lee MH, et al.
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (≤ 2.0 cm) in patients with hepatitis-induced liver cirrhosis[J]. Acta RadiolActa Radiol, 2013, 54(2): 127-136.
doi: 10.1258/ar.2012.120262 |
[15] |
Zhao XT, Li WX, Chai WM, et al.
Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?[J]. J Dig DisJ Dig Dis, 2014, 15(3): 137-145.
doi: 10.1111/1751-2980.12119 |
[16] |
Chen ML, Zhang XY, Qi LP, et al.
Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver[J]. Chin J Cancer ResChin J Cancer Res, 2014, 26(1): 38-47.
doi: 10.3978/j.issn.1000-9604.2014.01.07 |
[17] |
Kwon HJ, Byun JH, Kim JY, et al.
Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images[J]. Abdom ImagingAbdom Imaging, 2015, 40(1): 64-75.
doi: 10.1007/s00261-014-0188-8 |
[18] |
Forner A, Vilana R, Ayuso C, et al.
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma[J]. HepatologyHepatology, 2008, 47(1): 97-104.
doi: 10.1002/hep.21966 |
[19] |
Lim KS.
Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis[J]. Clin RadiolClin Radiol, 2014, 69(1): 1-10.
doi: 10.1016/j.crad.2013.07.022 |
[20] |
Piana G, Trinquart L, Meskine N, et al.
New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases[J]. J HepatolJ Hepatol, 2011, 55(1): 126-132.
doi: 10.1016/j.jhep.2010.10.023 |
[21] |
Nam SJ, Yu JS, Cho ES, et al.
High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions[J]. Clin RadiolClin Radiol, 2017, 72(3): 247-254.
doi: 10.1016/j.crad.2016.09.020 |
[22] |
Di PM, Briani C, Federici GF, et al.
Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules[J]. Clin ImagingClin Imaging, 2015, 39(3): 468-475.
doi: 10.1016/j.clinimag.2014.12.020 |
[23] |
Nakanishi M, Chuma M, Hige S, et al.
Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma[J]. Ann Surg OncolAnn Surg Oncol, 2012, 19(4): 1302-1309.
doi: 10.1245/s10434-011-2066-8 |
[24] |
Gluskin JS, Chegai F, Monti S, et al.
Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment Response[J]. J CancerJ Cancer, 2016, 7(11): 1565-1570.
doi: 10.7150/jca.14582 |
[25] |
Kim AY, Kim YK, Lee MW, et al.
Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis[J]. Acta RadiolActa Radiol, 2012, 53(8): 830-838.
doi: 10.1258/ar.2012.120099 |